Momenteel actieve connecties
Naam | Geslacht | Leeftijd | Verwante bedrijven | Samenwerking |
---|---|---|---|---|
John Henderson | M | 79 | 15 jaar | |
Santo Costa | M | 78 | 14 jaar | |
Wendell Wierenga | M | 76 | 13 jaar | |
Bradley Paul Morgan | M | 64 | 22 jaar |
Relatiegrafiek
Connectie in verschillende bedrijven
Oude connecties
Naam | Geslacht | Leeftijd | Verwante bedrijven | Samenwerking |
---|---|---|---|---|
Leonard Patrick Gage | M | 81 | 13 jaar | |
Paul Freiman | M | 89 |
Syntex Corp.
| 6 jaar |
Denise M. Gilbert | M | 66 | 7 jaar | |
James Brown | M | 67 |
Syntex Corp.
| 10 jaar |
James H. Sabry | M | 65 | 13 jaar | |
Andrew Wolff | M | 69 |
Syntex Corp.
| 26 jaar |
David Cragg | M | 68 | 17 jaar | |
Daniel J. Gennevois | M | 69 |
Roche Palo Alto LLC
Roche Palo Alto LLC Pharmaceuticals: MajorHealth Technology Roche Palo Alto LLC discovers and develops medicines. Its medicines are used for the treatment of central nervous system, inflammation, metabolism, oncology, and virology diseases. The company was founded in 1961 and is headquartered in Palo Alto, CA.
Syntex Corp.
| 9 jaar |
James Wilson | M | 80 |
Syntex Corp.
| 3 jaar |
Andrew R. Miksztal | M | - |
Syntex Corp.
Roche Palo Alto LLC
Roche Palo Alto LLC Pharmaceuticals: MajorHealth Technology Roche Palo Alto LLC discovers and develops medicines. Its medicines are used for the treatment of central nervous system, inflammation, metabolism, oncology, and virology diseases. The company was founded in 1961 and is headquartered in Palo Alto, CA. | 9 jaar |
Jose Balagot | M | - |
University of California, Santa Cruz
| 5 jaar |
Mark A. Schlossberg | M | 63 | 11 jaar | |
Jennifer Upham Saunders | F | - |
University of California, Santa Cruz
| 4 jaar |
Jonathan Drew Smith | M | - |
University of California, Santa Cruz
| 4 jaar |
John Burke | M | - |
University of California, Santa Cruz
| 2 jaar |
Keith R. Bley | M | 64 |
Syntex Corp.
| 9 jaar |
Alan F. Russell | M | 82 |
Syntex Corp.
| 12 jaar |
Scott Darling | M | 68 |
University of California, Santa Cruz
| 4 jaar |
Chris Adams | M | - |
University of California, Santa Cruz
| 4 jaar |
Robert Zuk | M | - |
Syntex Corp.
| 10 jaar |
George T. Jue | M | 71 |
Syntex Corp.
| 13 jaar |
Kurt Jarnagin | M | - |
Iconix Biosciences, Inc.
Iconix Biosciences, Inc. BiotechnologyHealth Technology Iconix Biosciences is a multi-disciplinary company that integrates the skills and knowledge necessary for the creation of the world's largest toxicogenomics database of microarray and pharmacology data (DrugMatrix) with the informatics expertise and computer skills required to mine and interpret this vast body of information. Based on the data in DrugMatrix, Iconix has developed a library of Drug Signatures, genomic biomarkers that are predictive of specific toxicological endpoints and mechanisms of action. DrugMatrix and Drug Signatures provide a uniform source of molecular toxicology information, analytical tools, data mining algorithms and biomarkers to optimize drug candidates and predict their potential efficacy and toxicity before they advance to expensive preclinical and clinical development studies. Iconix's platform includes an integrated database architecture (IXIS) to bridge genomics and drug design, novel bio and chemoinformatics software, and advanced expression array and cellular expression assay development capabilities. This technology platform is coupled with an unparalled group of molecular toxicologists and bioinformaticians with years of experience in applying the tools and contextual data to provide clients with answers to critical scientific questions. Iconix has focused these capabilities on a line of products, licenses, services, and long-term collaborations. Iconix provides reports on customer compounds to classify them and help prioritize and select the best leads for advancement at all stages of discovery. Iconix has also entered exclusive alliances with collaborators to apply toxicogenomics data and know-how to customized drug discovery and development projects. Founded in 1998 by distinguished scientists and pharmaceutical industry professionals, Iconix has won the backing of some of the highest profile venture capitalists in the biotechnology and information technology industries. Iconix has also established alliances with leading global technology companies for the development and commercialization of its products, including MDS Pharma Services, Spotfire, Amersham Biosciences, MDL Information Systems, and Affymetrix. | - |
Thomas L. Gutshall | M | 85 |
Syntex Corp.
| 5 jaar |
Christopher Bolling | M | - |
University of California, Santa Cruz
| 4 jaar |
Mark T. Edgar | M | - |
Syntex Corp.
| 16 jaar |
Larry Mattheakis | M | 67 | 5 jaar | |
Alan Russell | M | 54 | 8 jaar | |
Michael P. Dillon | M | 57 |
Syntex Corp.
| 2 jaar |
Gregory P. Adams | M | - |
University of California, Santa Cruz
| 4 jaar |
J. Doyne Farmer | M | 71 |
University of California, Santa Cruz
| 3 jaar |
Dan Gregerson | M | - |
University of California, Santa Cruz
| 3 jaar |
James Nickerson | M | - |
University of California, Santa Cruz
| 4 jaar |
Marjorie C. Wagman | F | - | - | |
John Mao | M | - | - | |
Marty Cagan | M | - |
University of California, Santa Cruz
| 4 jaar |
Jeffrey Finer | M | - | 9 jaar | |
Charles Krueger | M | - |
University of California, Santa Cruz
| 2 jaar |
Hilary Hefferlin | F | - |
University of California, Santa Cruz
| 4 jaar |
Eric B. Sjogren | M | 67 |
Syntex Corp.
| - |
Irwin A. Heyman | M | 82 |
Syntex Corp.
| 10 jaar |
Ray Roccaforte | M | - |
University of California, Santa Cruz
| 3 jaar |
Harold E. van Wart | M | 76 |
Syntex Corp.
| 8 jaar |
Jim Woody | M | 81 |
Roche Palo Alto LLC
Roche Palo Alto LLC Pharmaceuticals: MajorHealth Technology Roche Palo Alto LLC discovers and develops medicines. Its medicines are used for the treatment of central nervous system, inflammation, metabolism, oncology, and virology diseases. The company was founded in 1961 and is headquartered in Palo Alto, CA. | 7 jaar |
Peter Michael Algert | M | - |
University of California, Santa Cruz
| 4 jaar |
Yasuhiro Hashimoto | M | 68 |
Syntex Corp.
| - |
Jon Saxe | M | 88 |
Iconix Biosciences, Inc.
Iconix Biosciences, Inc. BiotechnologyHealth Technology Iconix Biosciences is a multi-disciplinary company that integrates the skills and knowledge necessary for the creation of the world's largest toxicogenomics database of microarray and pharmacology data (DrugMatrix) with the informatics expertise and computer skills required to mine and interpret this vast body of information. Based on the data in DrugMatrix, Iconix has developed a library of Drug Signatures, genomic biomarkers that are predictive of specific toxicological endpoints and mechanisms of action. DrugMatrix and Drug Signatures provide a uniform source of molecular toxicology information, analytical tools, data mining algorithms and biomarkers to optimize drug candidates and predict their potential efficacy and toxicity before they advance to expensive preclinical and clinical development studies. Iconix's platform includes an integrated database architecture (IXIS) to bridge genomics and drug design, novel bio and chemoinformatics software, and advanced expression array and cellular expression assay development capabilities. This technology platform is coupled with an unparalled group of molecular toxicologists and bioinformaticians with years of experience in applying the tools and contextual data to provide clients with answers to critical scientific questions. Iconix has focused these capabilities on a line of products, licenses, services, and long-term collaborations. Iconix provides reports on customer compounds to classify them and help prioritize and select the best leads for advancement at all stages of discovery. Iconix has also entered exclusive alliances with collaborators to apply toxicogenomics data and know-how to customized drug discovery and development projects. Founded in 1998 by distinguished scientists and pharmaceutical industry professionals, Iconix has won the backing of some of the highest profile venture capitalists in the biotechnology and information technology industries. Iconix has also established alliances with leading global technology companies for the development and commercialization of its products, including MDS Pharma Services, Spotfire, Amersham Biosciences, MDL Information Systems, and Affymetrix. | - |
Robert L. Roe | M | 83 |
Syntex Corp.
| 3 jaar |
Michael Schmertzler | M | 72 | 7 jaar | |
Jeffrey Cooper | M | 68 |
Syntex Corp.
| 12 jaar |
Thorsten von Stein | M | 62 |
Roche Palo Alto LLC
Roche Palo Alto LLC Pharmaceuticals: MajorHealth Technology Roche Palo Alto LLC discovers and develops medicines. Its medicines are used for the treatment of central nervous system, inflammation, metabolism, oncology, and virology diseases. The company was founded in 1961 and is headquartered in Palo Alto, CA. | 3 jaar |
Mark D. Cochran | M | 65 |
Syntex Corp.
| 9 jaar |
Gregory Leigh Lyons | M | 64 |
University of California, Santa Cruz
| 4 jaar |
Darlene J. Friedman | F | 81 |
Syntex Corp.
| 19 jaar |
David J. Loury | M | 68 |
Syntex Corp.
| 10 jaar |
Jay S. Laifman | M | 60 |
University of California, Santa Cruz
| 4 jaar |
A. Grant Heidrich | M | 71 | 13 jaar | |
Rockford Norby | M | 88 |
Syntex Corp.
| 6 jaar |
Elizabeth Dávila | F | 80 |
Syntex Corp.
| 17 jaar |
Melvin Booth | M | 79 |
Syntex Corp.
| 3 jaar |
John Martin | M | 72 |
Syntex Corp.
| 6 jaar |
Charles Homcy | M | 75 | 5 jaar | |
Karen S. Wright | F | 69 | 3 jaar | |
William J. Rutter | M | - | - | |
Neil William Flanzraich | M | 80 |
Syntex Corp.
| 13 jaar |
Virgil Thompson | M | 84 |
Syntex Corp.
| 24 jaar |
Fred Kurland | M | 74 |
Syntex Corp.
| 14 jaar |
Michael S. Rabson | M | 70 | 2 jaar | |
Gordon Ringold | M | 73 |
Syntex Corp.
| 24 jaar |
Hugo Madden | M | 75 |
Syntex Corp.
| 18 jaar |
Mark McDade | M | 69 | 4 jaar | |
Roberto Pedro Rosenkranz | M | 74 |
Syntex Corp.
| 2 jaar |
William Lee | M | 69 |
Syntex Corp.
| 1 jaar |
Steven Sordello | M | 54 |
Syntex Corp.
| 2 jaar |
Alan Dunton | M | 70 |
Syntex Corp.
| 2 jaar |
Bonnie Charpentier | M | 72 |
Syntex Corp.
| 4 jaar |
Jay K. Trautman | M | 65 | 6 jaar | |
Sharon Barbari | F | 70 | 13 jaar |
Statistieken
Land | Connecties | % van het totaal |
---|---|---|
Verenigde Staten | 81 | 100.00% |
Ouderdom van de connecties
Actief
Verleden
Man
Vrouw
Besturend
Uitvoerend
Oorsprong van de connecties
- Beurs
- Insiders
- David J. Morgans
- Persoonlijk netwerk